MDA5 and LGP2: accomplices and antagonists of antiviral signal transduction

J Virol. 2014 Aug;88(15):8194-200. doi: 10.1128/JVI.00640-14. Epub 2014 May 21.

Abstract

Mammalian cells have the ability to recognize virus infection and mount a powerful antiviral transcriptional response that provides an initial barrier to replication and impacts both innate and adaptive immune responses. Retinoic acid-inducible gene I (RIG-I)-like receptor (RLR) proteins mediate intracellular virus recognition and are activated by viral RNA ligands to induce antiviral signal transduction. While the mechanisms of RIG-I regulation are already well understood, less is known about the more enigmatic melanoma differentiation-associated 5 (MDA5) and laboratory of genetics and physiology 2 (LGP2). Emerging evidence suggests that these two RLRs are intimately associated as both accomplices and antagonists of antiviral signal transduction.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • DEAD-box RNA Helicases / metabolism
  • Host-Pathogen Interactions*
  • Humans
  • Immunity, Innate
  • Interferon-Induced Helicase, IFIH1
  • RNA Helicases / metabolism*
  • RNA Viruses / immunology*
  • Signal Transduction*

Substances

  • DHX58 protein, human
  • IFIH1 protein, human
  • DEAD-box RNA Helicases
  • Interferon-Induced Helicase, IFIH1
  • RNA Helicases